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Background: Hepatitis B virus (HBV) genotype F (HBV/F) is considered to be indigenous to the Americas, but its
emergence and spread in the continent remain unknown. Previously, only two HBV/F complete genome sequences
from Brazil were available, limiting the contribution of Brazilian isolates to the phylogenetic studies of HBV/F. The
present study was carried out to assess the proportion and geographic distributions of HBV/F subgenotypes in
Brazil, to determine the full-length genomic sequences of HBV/F isolates from different Brazilian geographic regions,
and to investigate the detailed evolutionary history and phylogeography of HBV/F in Brazil.
Methods: Complete HBV/F genomes isolated from 12 Brazilian patients, representing the HBV/F subgenotypes
circulating in Brazil, were sequenced and analyzed together with sequences retrieved from GenBank, using the
Bayesian coalescent and phylogeographic framework.
Results: Phylogenetic analysis using all Brazilian HBV/F S-gene sequences available in GenBank showed that
HBV/F2a is found at higher frequencies countrywide and corresponds to all sequences isolated in the Brazilian
Amazon Basin. In addition, the evolutionary analysis using complete genome sequences estimated an older median
ancestral age for the Brazilian HBV/F2a compared to the Brazilian HBV/F1b and HBV/F4 subgenotypes, suggesting
that HBV/F2a represents the original native HBV of Brazil. The phylogeographic patterns suggested a north-to-south
flow of HBV/F2a from Venezuela to Brazil, whereas HBV/F1b and HBV/F4 strains appeared to have spread from
Argentina to Brazil.
Conclusions: This study suggests a plausible route of introduction of HBV/F subgenotypes in Brazil and
demonstrates the usefulness of recently developed computational tools for investigating the evolutionary history of
HBV.
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Hepatitis B virus (HBV) infection is a major public health
problem worldwide. At least two billion people (one-third
of the global population) have been infected at some point
during their lives, and more than 240 million suffer from
chronic HBV infection, putting them at an increased risk
for liver cirrhosis and hepatocellular carcinoma [1].
The HBV genome is a partially double-stranded DNA
molecule of approximately 3.2 kilobases in length. It has
a highly compact coding structure consisting of four* Correspondence: nmaraujo@ioc.fiocruz.br
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reproduction in any medium, provided the oroverlapping reading frames, which are designated P
(polymerase), S (surface), C (core) and X (HBx protein).
HBV is a DNA virus that employs the error-prone poly-
merase reverse transcriptase as part of its replication
process [2]. For this reason, most estimates of the nu-
cleotide substitution rate for HBV range between 10-4 to
10−6 substitutions per site per year (s/s/y) [3-8], which is
far higher than those observed in other dsDNA viruses.
Eight HBV genotypes (A-H) have been recognized based
on a sequence divergence of more than 8% throughout the
genome [9-11]. More recently, two additional genotypes
(I and J) were tentatively proposed [12-14]. There is a
great deal of diversity within genotypes, leading to the div-
ision of some genotypes into subgenotypes [15,16]. Thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ical distribution of the genotypes: Genotypes A (HBV/A) and
HBV/D have worldwide distributions; HBV/B and HBV/C
are found essentially in Asia; HBV/E is confined to West and
Central Africa; HBV/G has been found in Europe, the USA
and Japan (and may be ubiquitous); and HBV/H is found in
Central America and the southern part of the USA [10,17].
The evolutionary history of HBV/F, which is one of
the most divergent HBV genotypes [18], is not well
understood due to the relative lack of appropriate stud-
ies. It is closely related to HBV/H [9], and probably orig-
inated in Amerindian populations, as it has been found
in the native populations of Alaska, Central America and
South America [9,19-25]. HBV/F has been divided into
four genetically distinct subgenotypes (HBV/F1-F4),
two of which have been further subdivided. HBV/F1 is
found in Central America (HBV/F1a) and Alaska and
South America (HBV/F1b). HBV/F3 is found in Central
America and in northern South America, whereas
HBV/F2 (HBV/F2a and HBV/F2b) [20] and HBV/F4 are
found in South America [26].
Brazil is the largest country in the Southern Hemisphere,
corresponding to almost half of the area of South America,
and is divided broadly into five geographic regions: north,
northeast, central west, southeast and south. Brazil has
a highly miscegenated population, with HBV/A, HBV/D
and HBV/F circulating among Brazilian HBV carriers
[23,27-29]. A large-scale study on the geographic distri-
bution of HBV genotypes in Brazil previously showed a
low countrywide prevalence of HBV/F (13%) [23]; this dif-
fers from other Latin American countries, where HBV/F
prevails [20,30-32]. However, a few studies on isolated
indigenous communities of Brazil have shown a predom-
inance of HBV/F [23,33,34]. Additionally, the Brazilian
Amazon region is a highly endemic area for HBV and
hepatitis delta virus (HDV); in this region, HBV/F has a
higher frequency among HBV-HDV co-infected patients
than in the general HBV-monoinfected population [35,36].
Previously, only two Brazilian HBV/F complete genome
sequences, GenBank accession numbers X69798 [37] and
HE981181 [38] were available, limiting the contribution of
Brazilian isolates to the phylogenetic studies of HBV/F.
Here, we examined the proportion and geographic dis-
tributions of HBV/F subgenotypes in Brazil, determined
the full-length genomic sequences of 12 HBV/F isolates
from different Brazilian geographic regions, and used the
Bayesian coalescent and phylogeographic framework to inves-
tigate the origin and spread of HBV/F subgenotypes in Brazil.
Results
Phylogenetic analysis of HBV/F S-gene sequences from
Brazil
To identify the HBV/F subgenotypes circulating in Brazil
and examine their proportion and geographic distributions,we initially performed a phylogenetic analysis using all
Brazilian HBV/F S-gene sequences available in GenBank
(n=53) (Figure 1). We focused on S-gene sequences be-
cause only two full-length Brazilian HBV/F genomes were
available prior to the present study. Of these 53 Brazilian
HBV/F S-gene sequences, 29 (54.7%) are from the north,
16 (30.2%) from the southeast, 4 (7.5%) from the central
west, 3 (5.7%) from the northeast, and 1 (1.9%) from the
south of Brazil.
The results of our phylogenetic analysis revealed that
HBV/F2a is the most prevalent HBV/F subgenotype in
Brazil, with 92.5% of the sequences clustering together
with HBV/F2a reference sequences. HBV/F4 (5.7%) and
HBV/F1b (1.9%) were also found among the Brazilian
sequences (Figure 1).
Concerning the geographic distributions of these
subgenotypes, HBV/F2a was found in all five Brazilian
geographic regions and corresponded to 100% (29/29) of
the sequences from the north, 100% (1/1) from the south,
87.5% (14/16) from the southeast, 75% (3/4) from the cen-
tral west, and 66.7% (2/3) from the northeast. HBV/F1b
was found in 33.3% (1/3) of the sequences from the north-
east, whereas HBV/F4 was found in 25% (1/4) of the se-
quences from the central west and 12.5% (2/16) of the
sequences from the southeast (Figure 2).
Thus, we obtained 12 full-length HBV sequences from
different Brazilian geographic regions representing the
three HBV/F subgenotypes circulating in Brazil: HBV/
F2a (north, n=1; northeast, n=3; central west, n=1;
southeast, n=4), HBV/F1b (northeast, n=1; southeast,
n=1) and HBV/F4 (southeast, n=1) (Additional file 1:
Table S1). Interestingly, one HBV/F1b complete genome
sequence was found in the southeast, where this
subgenotype had not been previously detected. These se-
quences were used in our Bayesian coalescent analysis.
Bayesian analyses of HBV/F complete genome sequences
To examine the time and starting point of diversification of
HBV/F subgenotypes in Brazil, we conducted Bayesian
Markov chain Monte Carlo (MCMC) analyses on 117
complete genome sequences (12 from our study and 105
from GenBank). We estimated the time of the most recent
common ancestor (tMRCA) of all internal nodes of the
maximum clade credibility (MCC) tree under a relaxed
molecular clock model. Since there is not a consensus on
the HBV substitution rate, we used three previously pub-
lished substitution rates: (i) 7.72 × 10-4 s/s/y obtained from
Bayesian approaches using complete genome sequences [6],
(ii) an “intermediate” rate in the range of previous estimates
of 1.0 × 10-5 s/s/y that was chosen by Torres and co-
authors to test one of the possible scenarios for the evolu-
tionary history of HBV/F [26] and (iii) a slower nucleotide
substitution rate of 2.2 × 10-6 s/s/y recently estimated using







Figure 1 Phylogenetic tree of partial S-gene (403 bp)
sequences inferred by using the neighbor-joining method.
Values at internal nodes indicate percentage of 1000 bootstrap
replicates that support the group. The horizontal bar indicates the
number of nucleotide substitutions per site. Brazilian sequences
available in GenBank are designated by their accession numbers,
followed by the geographic region of origin. The sequences
generated in this study are denoted BR, followed by the sample
number (1 to 12) and the geographic region of origin, and are
identified with ♦. HBV/F reference sequences are indicated by their
accession numbers, followed by the respective genotype/
subgenotype and the abbreviation of the origin country (ARG:
Argentina; BOL: Bolivia; COL: Colombia; ESa: El Salvador; FRA: France;
JAP: Japan; NIC: Nicaragua; PAN: Panama; PER: Peru; RIC: Costa Rica;
VEN: Venezuela), and are identified with *. Reference sequences for
the other genotypes are indicated by their accession numbers,
followed by the HBV genotype.
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found for HBV/F and its subgenotypes (Table 1). However,
an older median ancestral age for the Brazilian HBV/F2a
(HBV/F2a-BR) subgenotype compared to HBV/F1b-BR
and HBV/F4-BR could be estimated (Table 1). Figure 3
shows the time-scaled Bayesian MCC tree, in which the
sequences clustered into highly supported monophyletic
clades corresponding to the four HBV/F subgenotypes
(HBV/F1-F4). Our analyses indicated that most of the pos-
terior root state probability (PRSP) mass of HBV/F1b-BR
and HBV/F4-BR was placed in Argentina (PRSP = 0.91
and PRSP = 0.99, respectively), while HBV/F2a-BR root lo-
cation was most likely Venezuela (PRSP = 0.75) (Figure 3).
Therefore, these data suggest that Argentina and
Venezuela were the most probable locations from where
HBV/F1b and HBV/F4, and HBV/F2a, respectively, were
introduced into Brazil.
Discussion
HBV/F is thought to be the original genotype of the abo-
riginal populations of the Americas, since it has been
found in high frequencies in several countries of South
and Central America [19,24,30-32,39], as well as in na-
tive Alaskan populations [21,22]. HBV/H is also consid-
ered an Amerindian genotype, as it is found in Central
America, primarily in Mexico and Nicaragua [9,40].
Since HBV/F and HBV/H are closely related, it has been
suggested that these genotypes likely split off from each
other within the New World, via division of an ancestral
HBV strain carried by the first settlers that entered the
continent across the Bering Strait around 15,000 years
ago [9,41]. It has been estimated that the origin of HBV/
F and its subgenotypes precedes the European discovery
of the Americas by around 500 years ago [8,26]. Remark-
ably, over the first century and a half after the conquest
of the Americas, the native population plummeted by an
estimated 80% (from around 50 million in 1492 to 8 mil-
lion in 1650) [42]. This considerable reduction in the
Figure 2 Distribution of HBV/F subgenotypes in the Brazilian geographic regions (N - north; NE - northeast; CW - central west;
SE - southeast; S - south), based on 53 HBV/F S-gene sequences from Brazil available in GenBank.
Table 1 Estimated tMRCAs for HBV/F complete genome
sequences (GenBank accession numbers available in
Supplementary file 2
Group tMRCA (95% HPD) years
7.72 x 10-4 1.0 x 10-5 2.2 x 10-6
F/H 85 (37 – 178) 6,785 (3,468 – 13,857) 31,303 (14,989 – 58,828)
F 62 (33 – 101) 4,919 (2,984 – 8,978) 22,522 (13,401 – 35,422)
F1 21 (12 – 38) 1,764 (964 – 3,081) 7,753 (4,122 – 13,605)
F1a 6 (3 – 12) 520 (269 – 936) 2,358 (1,229 – 4,077)
F1b 13 (7 – 19) 1,020 (627 – 1,564) 4,483 (2,901 – 6,899)
F2 22 (12 – 35) 1,687 (870 – 2,865) 7,235 (4,103 – 11,433)
F2a 11 (6 – 18) 876 (506 – 1,433) 3,807 (2,221 – 5,973)
F2b 4 (2 – 8) 353 (204 – 608) 1,532 (850 – 2,626)
F3 11 (6 – 19) 884 (480 – 1,554) 3,961 (2,130 – 6,777)
F4 12 (7 – 21) 941 (503 – 1,643) 4,065 (2,347 – 6,824)
F1b-BR 2 (1 – 3) 137 (40 – 259) 587 (191 – 1,118)
F2a-BR 5 (3 – 7) 425 (278 – 668) 1,890 (1,201 – 3,006)
F4-BR 1 (0 – 3) 108 (14 – 263) 473 (62 – 1,143)
tMRCAs were calculated using three different substitution rates (7.72 x 10-4 [6],
1.0 x 10-5 [26] and 2.2 x 10-6 [8] substitutions per site per year).
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some HBV/F strains that were previously endemic in the
continent. However, the increase of the Latin American
population from the early 1800’s may have favoured
transmission of HBV/F in a highly endemic manner, fix-
ing the HBV/F1-F4 subgenotypes in the continent [26].
Unlike the other Latin American countries, where
HBV/F prevails [20,30-32], Brazil has a low countrywide
prevalence of HBV/F [23]. Even in the northern region
of Brazil (which includes the Amazon basin, where the
native Amerindian population predominates more than
in other regions of the country), low frequencies of
HBV/F have been detected [23,43-46]. Instead, a pre-
dominance of HBV/A, mainly HBV/A1, which was in-
troduced to the Americas probably during the slave
trade [28], has been observed. This may indicate that
there has been a change in the native genotypic profile
of the region, possibly due to the migratory influx that
has occurred in western Amazonia since the late 19th
and early 20th centuries, and the gradual reduction of in-
digenous communities over time [47]. Although the low
prevalence of HBV/F countrywide, our survey of HBV/F
S-gene sequences from Brazil available at GenBank
showed that HBV/F is found in all Brazilian geographic
regions, with most of the sequences (54.7%) isolated in
the north region, and there is circulation of three


































Figure 3 Time-scaled Bayesian Maximum Clade Credibility tree of HBV/F full length genome sequences calibrated with the
substitution rate of 1.0 × 10-5 s/s/y. The branches are colored according to the most probable location of their parental node (see the color
legend in the figure). The numbers on the internal nodes represent posterior probabilities (pp), and the branch lengths of the tree correspond to
length of time (see the time scale bar at the bottom of the tree). The symbol “▲” indicates the nodes corresponding to the posterior root state
probability (PRSP) values reported for HBV/F1b-BR, HBV/F2a-BR and HBV/F4-BR (0.91, 0.75, and 0.99, respectively). The two Brazilian HBV/F
complete genome sequences previously available in GenBank are identified with *.
Mello et al. Virology Journal 2013, 10:236 Page 5 of 8
http://www.virologyj.com/content/10/1/236Because there is no consensus about HBV evolutionary
rate, with most estimates ranging between 10-4 to 10−6
s/s/y, we decided to estimate the tMRCAs of the HBV/F
subgenotypes circulating in Brazil using three previously
published substitution rates, 7.72 × 10-4 [6], 1.0 × 10-5
[26] and 2.2 × 10-6 s/s/y [8]. Although the substitution
rate of 2.2 × 10-6 s/s/y was not obtained for the
complete genome, most tMRCA estimations from our
study and Paraskevis et al. [8] displayed an overlap of
95% HPD intervals. Among the HBV/F subgenotypes
circulating in Brazil, our analysis suggested an older an-
cestral age for HBV/F2a-BR compared to HBV/F1b-BR
and HBV/F4-BR. The median tMRCAs of HBV/F1b-BR
and HBV/F4-BR were very similar, which may suggest that
they appeared almost simultaneously. Inversely, HBV/F2a
has a lower tMRCA than HBV/F1b and HBV/F4 when all
HBV/F sequences were compared (Table 1). This fact indi-
cates that HBV/F2a probably emerged in the American
continent at a later time than the other two clades. Despite
this, HBV/F2a probably arrived and started to spread in
Brazil at an earlier time than HBV/F1b and HBV/F4. SinceBrazil was not pointed as the epicenter of dissemination of
any HBV/F clade, the time at which each clade started to
spread in South America is different from the time at
which each HBV/F clade started to spread in Brazil.
The tMRCA estimations using the substitution rates of
1.0 × 10-5 and 2.2 × 10-6 s/s/y (but not 7.72 × 10-4 s/s/y),
provided epidemiologically realistic scenarios for the evo-
lutionary history of HBV/F and its subgenotypes. Both
evolutionary rates supported the hypothesis that the
starting point of diversification of the strains ancestral to
HBV/F2a-BR in Brazil would have occurred in the pre-
Columbian Americas. However, some cautions are
necessary when interpreting these results, since the
number of HBV/F2a-BR sequences is greater than
HBV/F1b-BR and HBV/F4-BR sequences and this may
introduce a bias in tMRCA estimates. Noteworthy,
HBV/F2a has been found in all geographic regions of
Brazil, and is much more prevalent (92.5%) than HBV/F4
(5.7%) and HBV/F1b (1.9%). In addition, all HBV/F se-
quences from the Brazilian Amazon region correspond to
HBV/F2a, including five sequences (EF690487, EF690488,
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Amerindian Apurinã Tribe, thus corroborating the idea
that HBV/F2a is the oldest HBV/F subgenotype in Brazil
and may represent the original native HBV of the Brazilian
population.
HBV/F subgenotypes have a distinct geographical distri-
bution in the American continent. HBV/F1 has been fur-
ther subdivided into two sub-clusters, HBV/F1a and
HBV/F1b [39,48]. HBV/F1a remained restricted to Central
America, whereas HBV/F1b had a more complex distribu-
tion, being found mainly in South America (Argentina,
Brazil, Chile, Peru, and Venezuela). Curiously, HBV/F1b
is also found in the native populations of Alaska. In our
analysis, the Alaskan sequences grouped far from the
HBV/F1 root, suggesting a relatively recent migration.
This notion is supported by a paper that also suggested a
relatively recent introduction of this genotype in Alaska
[21]. Likewise, HBV/F2 separated into two sub-clusters,
HBV/F2a and HBV/F2b [20]. HBV/F2b remained re-
stricted to Venezuela, whereas HBV/F2a is found almost
exclusively in Brazil and Venezuela, with the exception of
one HBV/F2a sequence (GenBank accession number
AY090455) isolated in Nicaragua. HBV/F3 is found in
Central America, Colombia and Venezuela, while HBV/F4
in Argentina, Bolivia and Brazil. Our data suggest a plaus-
ible route of introduction of HBV/F subgenotypes in Brazil.
The phylogeographic patterns indicated that Venezuela
was the most probable origin for HBV/F2a that has subse-
quently spread countrywide, indicating a north-to-south
net viral flow in Brazil. On the other hand, although the
limited number of Brazilian HBV/F1b and HBV/F4 se-
quences, these strains appeared to have spread from the
south to the north, being Argentina the most probable epi-
center of introduction of these subgenotypes in Brazil.
Conclusions
We herein employed the Bayesian coalescent and
phylogeographic framework to investigate the evolution-
ary history of HBV/F and the complex factors underlying
its origin in Brazil. Our study suggests a plausible route
of introduction of HBV/F subgenotypes in Brazil and
provides full-length genomic sequences of HBV/F iso-
lates from different Brazilian geographic regions, which
will increase the contribution of Brazilian isolates to fur-
ther phylogenetic studies of HBV/F.
Methods
DNA extraction and molecular assays
HBV-DNA were extracted from a total of 29 HBeAg posi-
tive serum samples taken from different geographic re-
gions of Brazil, previously characterized as having HBV/F
strains. However, the amplification and sequencing of the
complete genome were successfully performed in 12 sam-
ples: southeast (n=6), northeast (n=4), central west (n=1),and north (n=1) (Additional file 1: Table S1). The Ethics
Committee of Oswaldo Cruz Institute reviewed and ap-
proved the research protocol. All participating individuals
gave written informed consent.
HBV DNA was extracted from 0.2 mL of serum using a
High Pure Viral Nucleic Acid kit (Roche Diagnostics,
Germany) according to the manufacturer’s instructions.
The full-length HBV genome was amplified as previously
described [49] and purified using the Wizard SV Gel and
PCR Clean-Up System (Promega, WI, USA). HBV nucleo-
tide sequences were determined using a BigDye Terminator
kit (Applied Biosystems, CA, USA) and the previously de-
scribed primers [50]. Sequencing reactions were analyzed
on an ABI3730 automated sequencer (Applied Biosystems).
The nucleotide sequences obtained during this study were
deposited in the GenBank database under accession num-
bers KC494394-KC494405.
HBV/F S-gene sequence dataset from Brazil
All HBV/F S-gene sequences from Brazil available in
GenBank by October 2012 (n=53) were selected for
phylogenetic analysis. Reference sequences for HBV ge-
notypes A-J were also included in the analysis. The
phylogenetic relationships among the S-gene sequences
were evaluated with the neighbor-joining method (1000
bootstrap replicates) using MEGA version 5.1 [51].
Bayesian phylogenetic and phylogeographic analyses
The 12 complete HBV/F genome sequences generated in
this study were combined with 105 full-length HBV/F se-
quences from North, Central and South America and Japan
(GenBank accession numbers available in Additional file 2:
Table S2). All selected sequences had country data available
and were classified as non-recombinant. The sampling lo-
cations included Argentina (n=24), Bolivia (n=7), Brazil
(n=2), Chile (n=21), Colombia (n=2), Japan (n=2), Peru
(n=2), USA (n=11) and Venezuela (n=26). The sequences
from Costa Rica (n=2), El Salvador (n=2), Nicaragua (n=2),
and Panama (n=2) were grouped as representing Central
America. A reference sequence from HBV/H was also in-
cluded in the analysis.
The tMRCA and the spatial diffusion for the full-length
sequences of HBV/F and its subgenotypes were jointly es-
timated using the Bayesian MCMC statistical framework
implemented in the BEAST v1.7.4 package [52,53]. A
matrix of geographic locations was constructed based on
the sampling location for each sequence. A full model
was used in which all possible reversible exchange rates
between locations were equally likely (flat prior) [54].
Analyses were carried out with a Bayesian Skyline co-
alescent tree [55] under the model of nucleotide substi-
tution TVM + Γ + I, which was selected as the best-fit
model by the jModeltest program [56]. We used a re-
laxed (uncorrelated Lognormal) molecular clock model
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lating the Bayes Factor from the posterior output of each
model using TRACER v1.4 [58]. The time-scale of the
Bayesian tree was calibrated using three previously pub-
lished substitution rates, 7.72 × 10-4 [6], 1.0 × 10-5 [26] and
2.2 × 10-6 s/s/y [8]. MCMC analysis was run for 5 × 107
generations to achieve the convergence of parameters,
which was assessed after a 10% burn-in and calculation of
the Effective Sample Size (ESS) using TRACER v1.4. All
parameter estimates showed ESS values >200, and their un-
certainty was reflected in the 95% Highest Posterior Density
(HPD) intervals. The MCC tree was visualized using the
FigTree v.1.3.1 program after the posterior tree distribution
was summarized using the TreeAnnotator v.1.7.4 program.
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study.
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